News
-
-
PRESS RELEASE
ASTCT Supports the FDA’s Accelerated Approval of AMTAGVI for Treatment of Metastatic Melanoma
The American Society for Transplantation and Cellular Therapy supports FDA's accelerated approval of lifileucel for unresectable or metastatic melanoma, offering new hope in solid tumor cancer treatment -
PRESS RELEASE
American Society for Transplantation and Cellular Therapy Awards Robin Roberts With the 2024 Public Service Award
The American Society for Transplantation and Cellular Therapy will honor Robin Roberts with the 2024 Public Service Award for her advocacy in raising awareness for bone stem cell transplant and advancing breakthroughs in HCT and cell therapy -
PRESS RELEASE
Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists to Gather for the 2024 Tandem Meetings
The 2024 Tandem Meetings will unite international hematopoietic cell transplantation and cellular therapy specialists to discuss advancements and share insights in healthcare. The event will feature plenary and concurrent sessions, late-breaking abstracts, a poster hall, and an exhibit hall -
PRESS RELEASE
ASTCT, AACI, and ACCC Launch RECUR Initiative to Enhance Patient Access to CAR T Therapy
The American Society for Transplantation and Cellular Therapy (ASTCT), the Association of American Cancer Institutes (AACI), and the Association of Community Cancer Centers (ACCC) have announced the RECUR initiative, a collaborative effort to revolutionize the evaluation process for CAR T therapy. The initiative focuses on crucial factors to ensure timely and personalized care, aiming to empower healthcare professionals and patients with an understanding of successful CAR T therapy. Through educational programs and resources, the initiative seeks to support professionals and patients in navigating the complexities of CAR T therapy. -
-
